Extremity Medical, LLC announces the continued plan to release innovative products to its portfolio in 2018. Currently, Extremity Medical has 20 products released globally which include specialized fixation, advanced arthroplasty systems, and biologics for the distal lower and upper extremities.
In 2017, Extremity Medical added several unique products to its ever-growing portfolio:
- AXIS Charcot Fixation System: 510(k) cleared for Charcot indications, this comprehensive beaming system provides implants designed to deliver biomechanical advantages which allow for a “superconstruct” type of fixation in these challenging cases. Well over 120 cases have utilized Axis since its mid-year release with outstanding results.
- Omni MTP Fusion System: a unique system which offers all of the traditional methods of fixation for MTP fusions with the addition of novel, patent pending technology that is designed to allow surgeons the ability to gain consistent plantar side compression of the joint regardless of the patient’s bone quality.
- BioFuse: a next generation live cell bone graft which utilizes scientific advancements in processing to enhance the three key components needed for bone regeneration: osteogenesis, osteoinductivity, and osteoconductivity.
- Jones Fracture System: this system has been engineered to optimize screw purchase and compression, and provides
novel instrumentation designed to encourage healing in the unique anatomy of the 5th metatarsal.
Extremity Medical will look to release several new products to its portfolio in 2018:
- Omni Plating System: this comprehensive foot plating system will leverage the patent pending technology of the Omni MTP Fusion System for expansion into the hind, mid and forefoot indications.
- AlignX Lateral Plating System: lateral plates for both tibiotalar, and tibiotalar-calcaneus fusions will be added to the popular AlignX Ankle Fusion System’s anterior plate offering.
- Charcot Plating System: Charcot specific plates will be added to Extremity Medical’s Charcot foot offering.
- Freedom: a next generation fixation system with novel features designed to leverage compression while enhancing the ease and speed of implant delivery.
Matt Lyons, Chairman and CEO of Extremity Medical commented, “over the last several years I have stated that our goal has been to develop innovative products that significantly impact the extremity surgeon’s ability to treat challenging patient conditions. In 2017, we met that goal with the release of several highly-differentiated products. We will continue this product rollout strategy in 2018”
